Sexual dysfunction study for women


16377

A Placebo-Controlled, Randomized, Double-Blind, Parallel-Group, Dose-Finding Trial to Evaluate the Efficacy and Safety of TBS-2 Intranasal Testosterone Gel in Women With Acquired Female Orgasmic Disorder

Psychiatry and Neurobehavioral Sciences

Clayton Anita, H

UVa Health System, Department of Psychiatry & Neurobehavioral Sciences seeks women ages 18-65 experiencing a lack of orgasm for a research study. The purpose of the study is to evaluate the effectiveness of a study medication in women with an absence of an orgasm. The study involves the following procedures: taking an experimental medicine or placebo, having vital signs, blood draws, EKG, a mammogram, pelvic exam, and physical exam. Patient participation requires 5 visits over 3 months. Be assured that your personal information is kept in such a way that your confidentiality is respected. Study-related exams, tests and experimental medication will be provided free of charge. Study patients may be provided compensation for each completed visit in the total amount of $225. For more information please contact: Mindy Borszich: 434-243-4631, mcb3x@virginia.edu IRB-HSR # 16377 Principal Investigator: Dr. Anita H. Clayton

Center for Psychiatric Clinical Research

Adult

Sexual Dysfunction

Women's Health
Psychiatry/Psychology

Ill

Compensation

Mindy Borszich

mcb3x@virginia.edu

4342434631